Study of inflammation-related coronary artery disease
Part of Heart & circulation clinical trials.
This study compares two types of coronary artery disease: one linked to inflammation (IR-CAD) and the standard type (AS-CAD). If you have had a heart procedure and were recently hospitalized for worsening chest pain, this study may help doctors understand your condition better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You have had a procedure to open blocked heart arteries (like angioplasty or bypass surgery)
- You are currently taking standard heart medications to prevent future heart problems
- You were recently hospitalized due to quickly worsening chest pain or heart-related symptoms within the last 6 months
- You have lab results or a diagnosis showing inflammation (like high CRP, ESR, or an autoimmune disease)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people who have both coronary artery disease (narrowed heart arteries) and signs of chronic inflammation to learn more about their condition, current treatments, and outcomes. It helps doctors understand how best to care for patients like you.
This study looks at whether a comprehensive add-on treatment—starting with immune medicine and then a heart procedure when needed—can improve outcomes for people whose coronary artery disease is getting worse quickly. It focuses on cases where inflammation is likely driving new artery blockages or worsening chest pain.
This study follows adults who have fast, unexplained re-narrowing of a coronary stent, to better understand what causes it and how to monitor it. You may help by allowing the study team to collect medical information over time.
This study looks at a specific type of coronary artery disease that gets worse quickly despite treatment. It compares people who have this rapid worsening to those whose condition is stable, to learn more about the disease and possibly find better ways to manage it.
This study tests a new medicine called YMI024 for people with stable coronary artery disease (blockages in heart arteries) and higher than normal levels of inflammation. The drug aims to reduce inflammation and may lower the risk of future heart problems.
This study aims to match people with angina (chest pain from heart artery problems) to the most helpful treatment plan based on their test results. It’s done around the time doctors are planning an invasive heart scan to look at the coronary arteries.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.